Fortress Biotech, Inc. (FBIO) 13D/13G Filings for Avenue Therapeutics, Inc. (ATXI)

Fortress Biotech, Inc. 13D and 13G filings for Avenue Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-01-06
4:31 pm
Purchase		 2022-12-31 13D Avenue Therapeutics, Inc.
ATXI		 Fortress Biotech Inc.
FBIO		 7,710
11.300%		 4,296increase
(+125.86%)		 Filing